«Polyar» is a project company, developing an innovative anti-inflammatory drug, an inhibitor of inducible nitric oxide synthase (codename – LIS). The drug is patented in Russia, USA, EU. The drug is indicated for treating inflammatory and autoimmune diseases (including arthritis) with concomitant severe pain. The drug exerts potent analgesic and anti-inflammatory action, effective in autoimmune arthritis, doesn’t have adverse effect towards the gastrointestinal tract. Currently, preclinical trials of the drug are ongoing.